Atria Investments’s Novanta NOVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.1M Buy
6,760
+1,564
+30% +$226K 0.01% 1062
2026
Q1
$614K Buy
5,196
+1,053
+25% +$138K 0.01% 1332
2025
Q4
$493K Buy
4,143
+501
+14% +$57.1K 0.01% 1458
2025
Q3
$365K Buy
3,642
+611
+20% +$72.7K ﹤0.01% 1606
2025
Q2
$391K Buy
3,031
+305
+11% +$37.1K ﹤0.01% 1560
2025
Q1
$349K Buy
2,726
+139
+5% +$20K ﹤0.01% 1537
2024
Q4
$395K Sell
2,587
-372
-13% -$63K ﹤0.01% 1439
2024
Q3
$529K Sell
2,959
-1,067
-27% -$185K 0.01% 1289
2024
Q2
$657K Buy
+4,026
New +$653K 0.01% 1167
2024
Q1
– Sell
-6,162
Closed -$1.04M – 997
2023
Q4
$1.04M Buy
+6,162
New +$898K 0.02% 879
2022
Q2
– Sell
-7,278
Closed -$1.04M – 837
2022
Q1
$1.04M Buy
7,278
+412
+6% +$58.5K 0.02% 841
2021
Q4
$1.21M Buy
+6,866
New +$1.15M 0.02% 758
2020
Q2
– Sell
-2,636
Closed -$211K – 690
2020
Q1
$211K Buy
+2,636
New +$235K 0.02% 519

Other funds holding NOVT

Atria Investments's NOVT Position: Q2 2026 in Review

Atria Investments increased its Novanta (NOVT) stake by 30% in Q2 2026, buying an estimated $226K and bringing the position to 6,760 shares worth $1.1M. The position accounts for 0.01% of the portfolio, ranked #1062.

Atria Investments first reported a position in NOVT in Q1 2020 and has held it in 13 quarters since. The position peaked at $1.21M in Q4 2021. 391 funds tracked by Wall St. Rank hold NOVT as of Q2 2026.

  • Atria Investments held 6,760 shares of Novanta worth $1.1M as of Q2 2026.
  • Atria Investments bought 1,564 Novanta shares in Q2 2026, an estimated $226K.
  • Novanta made up 0.01% of Atria Investments's portfolio in Q2 2026, its #1062 holding.
  • Atria Investments first reported a position in Novanta in Q1 2020 and has held it in 13 quarters since.
  • Atria Investments's Novanta position peaked at $1.21M in Q4 2021.
  • 391 funds tracked by Wall St. Rank held Novanta as of Q2 2026.

Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.